A groundbreaking study, the REBOOT Trial, has revealed that beta blockers may pose greater risks to women after a heart attack, challenging decades of standard treatment practices. This pivotal research could reshape clinical guidelines worldwide.
A groundbreaking study reveals that beta blockers may not benefit heart attack patients with preserved heart function. Discover the surprising results that could change treatment protocols.
